<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="384">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05156151</url>
  </required_header>
  <id_info>
    <org_study_id>EyehospitalPrishtina</org_study_id>
    <nct_id>NCT05156151</nct_id>
  </id_info>
  <brief_title>Stromal Lenticule Implantation for Management of Herpetic Stromal Keratitis</brief_title>
  <acronym>Relex-Smile</acronym>
  <official_title>Stromal Lenticule Implantation for Management of Herpetic Stromal Keratitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eye Hospital Pristina Kosovo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eye Hospital Pristina Kosovo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is the evaluation of corneal transparency and improvement of visual&#xD;
      acuity in patients with herpetic stromal keratitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stromal keratitis is an infectious ocular disease of either necrotizing or non-necrotizing&#xD;
      form, due to an HSV infection, and characterized by corneal stromal necrosis, inflammation,&#xD;
      ulceration and infiltration by leukocytes.&#xD;
&#xD;
      In our study these early findings suggest that the use of corneal stromal lenticules with&#xD;
      stromal stem cells and live keratocytes could be a safe and efficient treatment for stromal&#xD;
      scar after herpetic keratitis, and excluding the recurrence of the disease by removing the&#xD;
      corneal scar after herpetic infection using Smile and implanting the lenticule equal to the&#xD;
      volume of the removed scar tissue.&#xD;
&#xD;
      Stromal lenticule implantation is relatively simple, low-cost and offers advantages over&#xD;
      corneal transplantation as a definitive procedure in the treatment of this disease.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal transparency</measure>
    <time_frame>12 months</time_frame>
    <description>Implantation of corneal stromal lenticules with stromal stem cells, live keratocytes and telocytes, stromal haze and scar have been successfully treated and stabilized the biomechanical stability of cornea in 87% of the patients which underwent this treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of visual acuity</measure>
    <time_frame>12 months</time_frame>
    <description>Implantation of fresh corneal lenticule resulted in the visual acuity according to the clarity of cornea.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Stromal Keratitis</condition>
  <arm_group>
    <arm_group_label>Stromal lenticule implantation for management of herpetic stromal keratitis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The thickness of the herpetic stromal scar in the cornea is calculated in microns in OCT. Based on that extraction is performed using SMILE, a new lenticular stromal pocket is placed in the same volume. AS-OCT evaluated the corneal topography, glass-corrected best visual acuity (BSCVA) measurements and electron microscopy. Postoperative complications were monitored during the follow-up period.&#xD;
During the three year follow-up period, no signs of recurrence or infections were detected in this patient.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Relex-Smile</intervention_name>
    <arm_group_label>Stromal lenticule implantation for management of herpetic stromal keratitis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  low transparenc of cornea&#xD;
&#xD;
          -  low visual acuity&#xD;
&#xD;
          -  recurrence of herpetic stromal keratitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previous corneal or anterior segment surgery&#xD;
&#xD;
          -  any infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>46 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eye Hospital Pristina</name>
      <address>
        <city>Pristina</city>
        <zip>10000</zip>
        <country>Kosovo</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kosovo</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>October 25, 2021</study_first_submitted>
  <study_first_submitted_qc>December 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 14, 2021</study_first_posted>
  <last_update_submitted>December 8, 2021</last_update_submitted>
  <last_update_submitted_qc>December 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Eye Hospital Pristina Kosovo</investigator_affiliation>
    <investigator_full_name>Dr. Faruk Semiz</investigator_full_name>
    <investigator_title>Head of Ophthalmology Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

